In the study, the researchers examined the outcomes of 594 patients who underwent kidney transplantation over a 10-year period. They tracked CMV infection incidence, transplanted kidney function loss and damage, the transplant lifespan and patient survival rates.
Ultimately, they found patients who developed CMV had a higher prevalence of damage to the transplanted kidney before the infection even occurred, meaning transplant damage was more likely related to the organ donor and not the infection.
Additionally, they discovered transplant failure was associated with older donor age and poor transplant function occurring soon after operation. CMV infection incidence was not actually a significant factor in the study.
More articles on transplants:
UPMC stops organ transplants to investigate, contain mold problem
University of Michigan Health System creates hand transplant program
More minority patients receiving kidney transplants
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
